人人揉揉揉揉揉日日aV,内射白嫩少妇超碰,香港a毛片在线视频观看,日日摸夜夜添夜夜添视频

NBS5880 (1S,3R)-RSL3 (GPx4 inhibitor)谷胱甘肽過(guò)氧化物酶4抑制劑

欄目:NoninBio
(1S,3R)-RSL3 (GPx4 inhibitor)谷胱甘肽過(guò)氧化物酶4抑制劑
貨號(hào):NBS5880-10mg;
NBS5880-50mg;
NBS5880-100mg
品牌:NoninBio

 

(1S,3R)-RSL3 (GPx4 inhibitor)谷胱甘肽過(guò)氧化物酶4抑制劑

 

產(chǎn)品編號(hào)

產(chǎn)品名稱(chēng)

包裝規(guī)格

價(jià)格

NBS5880-10mg

(1S,3R)-RSL3 (GPx4 inhibitor)

10mg

566

NBS5880-50mg

(1S,3R)-RSL3 (GPx4 inhibitor)

50mg

1654

NBS5880-100mg

(1S,3R)-RSL3 (GPx4 inhibitor)

100mg

2654

 

產(chǎn)品簡(jiǎn)介:

(1S,3R)-RSL3是一種谷胱甘肽過(guò)氧化物酶4GPX4) 抑制劑,誘導(dǎo)致命性的脂質(zhì)氫過(guò)氧化物累積和鐵死亡。與野生型BJeHLT細(xì)胞(EC50 = 2 μM)相比,選擇性作用于表達(dá)HRASV12BJeHLT細(xì)胞(EC50 = 0.01 μM)。各種小鼠移植瘤模型中,(1S,3R)-RSL3減少腫瘤體積,其中帶彌漫大B細(xì)胞淋巴瘤和腎細(xì)胞癌的模型最敏感。

 

產(chǎn)品特性

1) 化學(xué)名:(1S,3R)-Methyl 2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-[4

-(methoxycarbonyl)phenyl]-1H-pyrido[3,4-b] indole-3-carboxylate

2CAS NO1219810-16-8

3) 同義名:RSL3

4) 分子式:C23H21ClN2O5

5) 分子量:440.88

6) 外觀:固體

7) 純度:≥98%

8) 溶解性:溶于DMSO30mg/ml)、乙醇(25mg/ml)、DMF30mg/ml

 

保存條件

-20℃避光干燥保存,至少2年有效。

 

 

本產(chǎn)品僅用于生命科學(xué)研究,不得用于醫(yī)學(xué)診斷及其他用途!



儲(chǔ)存液制備:

質(zhì)量

溶劑體積

濃度

1mg

5mg

10mg

1mM

2.2682 mL

11.3410 mL

22.6819 mL

5mM

0.4536 mL

2.2682 mL

4.5364 mL

10mM

0.2268 mL

1.1341 mL

2.2682 mL

【溫馨提示】:請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液置于-80°C保存,約6個(gè)月有效;-20°C保存,約1個(gè)月有效。溶液儲(chǔ)存的過(guò)程中避免強(qiáng)光直射。

 

產(chǎn)品使用: 【源自文獻(xiàn),僅作參考】

文獻(xiàn)1,Zhang, W.; Li, X.; Xu, J.; Wang, Y.; Xing, Z.; Hu, S.; Fan, Q.; Lu, S.; Cheng, J.; Gu, J.; Cai, R. The RSL3 Induction of KLK Lung Adenocarcinoma Cell Ferroptosis by Inhibition of USP11 Activity and the NRF2-GSH Axis. Cancers 2022, 14, 5233. https://doi.org/10.3390/cancers14215233

 

體外研究(細(xì)胞水平):

細(xì)胞類(lèi)型(Cell Type):A549 and H2122 cells

實(shí)驗(yàn)方法(Assay):A549 cells were treated withdimethyl sulfoxide (DMSO) or RSL3 (4 μM) for 12 hand H2122 cells were treated withDMSO or RSL3 (8 μM) for 12 h and then subjected to CCK-8 assay.

 

體內(nèi)研究(動(dòng)物模型):

動(dòng)物模型(Animal Model):10-week-old male nude micewere subcutaneously injected with A549 cells (100 μL containing 5 × 106 cells/injection) and monitored for tumor cell xenografts to reach approximately 100 mm3. 

實(shí)驗(yàn)方法(Assay):The mice were then divided into two groups (n = 5), the RSL3 treatment (100 mg/kg; dissolved in 5% dimethyl sulfoxide/corn oil; administrated intratumorally twice a day for one week) and control (5% dimethyl sulfoxide/corn oil only) groups. After that, the mice were sacrificed, and tumor weight was measured respectively.


注意事項(xiàng):

1.      針對(duì)溶解性比較差的化合物,可通過(guò)37℃孵育以及超聲的方式來(lái)促進(jìn)其溶解。

2.      本品并非商業(yè)化的臨床藥物,僅用作科研用途,不得用作臨床診斷或治療,不得用于食品或藥品,絕對(duì)禁止用在人身上。 

3.      為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。


相關(guān)產(chǎn)品:

產(chǎn)品編號(hào)

產(chǎn)品名稱(chēng)

包裝規(guī)格

NBS5878-5g

Ferrostatin-1 鐵死亡抑制劑

5g

NBS5879-1mg

Erastin愛(ài)拉斯?。ㄨF死亡激活劑)

1mg

NBS5880-10mg

(1S,3R)-RSL3 (GPx4 inhibitor)谷胱甘肽過(guò)氧化物酶4抑制劑

10mg

NBS5881-1mg

BCP-T.A. (Ferroptosis inducer)鐵死亡誘導(dǎo)劑

1mg

NBS5882-2mg

Liproxstatin-1 鐵死亡抑制劑

2mg

NBS5883-1g

Deferiprone (DFP)去鐵酮(鐵螯合劑)

1g

NBS5884-25mg

Deferoxamine Mesylate甲磺酸去鐵胺(鐵螯合劑)

25mg

NBS5885-1g

FINO2(Ferroptosis inducer)鐵死亡誘導(dǎo)劑

1g

NBS5886-50ug

FeRhoNox-1 (Fe2+ indicator) 亞鐵離子熒光探針

50ug

NBS5887-24ug

FerroOrange (Fe2+ indicator) 亞鐵離子熒光探針

24ug

NBS5888-50nmol

FerroFarRed (Fe2+ indicator) 亞鐵離子熒光探針

50nmol